Recent News

Jun 18, 2021

News Scan for Jun 18, 2021

TB outbreak tied to spinal surgery
Excess deaths in Switzerland
COVID-19 convalescent plasma in cancer patients
Polio in 7 countries
Low global flu rates
Jun 16, 2021

Stewardship / Resistance Scan for Jun 16, 2021

Antibiotic development legislation
Shorter regimen for drug-susceptible TB
Mar 24, 2021
Man receiving tuberculosis drugs

World TB Day highlights challenges—and hope

Until COVID, TB was the world's top infectious cause of death, and the pandemic threatens to derail efforts to curtail it.

Feb 15, 2021

News Scan for Feb 15, 2021

Trial for resistant-TB drug
Listeria cheese outbreak
Hemolytic uremic syndrome in children
Dec 09, 2020

News Scan for Dec 09, 2020

Earliest Italian COVID case
COVID and essential workers
WHO global health estimates
More avian flu in Europe
Nov 17, 2020

News Scan for Nov 17, 2020

UK dental antibiotic prescribing
Gaps in global TB progress
More H5N8 avian flu in Europe
Chapare virus transmission
Oct 21, 2020

Stewardship / Resistance Scan for Oct 21, 2020

Novel treatment access for drug-resistant TB
Grant for sepsis treatment
Oct 14, 2020
TB control efforts in India

WHO warns of COVID impact on TB services

Tuberculosis notifications in the hard-hit countries of India, Indonesia, and the Philippines have fallen 25% to 30% because of pandemic-related disruptions.

Aug 13, 2020

News Scan for Aug 13, 2020

MDR-TB infections in Ohio
US gears up for flu vaccination
Severe COVID-19 risk factors
Aug 11, 2020
Vaccine development

Pandemic total tops 20 million amid Russian vaccine news, New Zealand flare-up

Russia's vaccine hasn't been through phase 3 trials, raising worries that the country is skipping key safety steps.

Resources & Literature

Recent Literature

Alemu A, Bitew AW, Worku T. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysis. Int J Infect Dis 2020 (published online Jul 6)

Arinaminpathy N, Sinha A, Anvikar A, et al. Infectious diseases in the South-East Asia region. CDDEP 2021 (published online Feb 23)

Bachir M, Guglielmetti L, Tunesi S, et al. Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events. Int J Infect Dis 2021 (published online Apr 3)

Baik Y, Rickman HM, Hanrahan CF, et al. A clinical score for identifying active tuberculosis while awaiting microbiological results: development and validation of a multivariable prediction model in sub-Saharan Africa. PLoS Med 2020 (published online Nov 10)

Balaishvili D, Gandhi NR, Kim S, et al. Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study. Clin Infect Dis 2021 (published online Mar 27)

Basham CA, Smith SJ, Romanowski K, et al. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: a systematic review and meta-analysis. PLoS One 2020 (published online Jul 10)

Bishara H, Green M, Chemtob D, et al. Ongoing tuberculosis transmission among second-generation Ethiopian immigrants in Israel. Epidemiol Infect 2020 (published online Aug 3)

Bishara H, Green M, Chemtob D, et al. Ongoing tuberculosis transmission among second-generation Ethiopian immigrants in Israel. Epidemiol Infect 2020 (published online Aug 3)

Brust JC, Gandhi NR, Wasserman S, et al. Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study. Clin Infect Dis 2021 (published online Apr 21)

Bupta RK, Calderwood CJ, Yavlinsky A, et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med 2020 (published online Oct 19)

Burusie A, Enquesillassie F, Addissie A, et al. Effect of smoking on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS One 2020 (published online Sep 17)

Chakaya J, Khan M, Ntoumi F, et al. Global tuberculosis report 2020: reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis 2021 (published online Mar 11)

Chidambaram V, Tun NL, Majella MG, et al. Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: a retrospective cohort study, a systematic review of the literature, and meta-analysis. Clin Infect Dis 2021 (published online Jun 8)

Collins JM, Stout JE, Ayers T, et al. Prevalence of latent tuberculosis infection among non-U.S.–born persons by country of birth—United States, 2012-2017. Clin Infect Dis 2020 (published online Nov 2)

Cronin AM, Railey S, Fortune D, et al. Effects of the COVID-19 response on tuberculosis prevention and control efforts—United States, March-April 2020. MMWR (Notes from the field) Jul 24;69(29):971-2

Cudahy PG, Wilson D, Cohen T. Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study. BMC Infect Dis 2020 Oct 23;20:789

Dale KD, Karmakar M, Snow KJ, et al. Quantifying the rates of late reactivation tuberculosis: a systematic review. Lancet Infect Dis 2021 (published online Apr 20)

Dara M, Kuchukhidze G, Yedibayev A, et al. Early COVID-19 pandemic's toll on tuberculosis services, WHO European Region, January to June 2020. Eurosurveill 2021 Jun 17;26(24)

De Oliveira RD, da Silva Santos A, Reis CB, et al. Primary prophylaxis to prevent tuberculosis infection in prison inmates: a randomized, double-blind, placebo-controlled trial. Am J Trop Med Hyg 2020 (published online Aug 31)

DesJardin CP, Chirenda J, Ye W, et al. Factors associated with unfavorable treatment outcomes among pediatric tuberculosis cases in Harare, Zimbabwe during 2013–2017. Int J Infect Dis 2020 (published online Sep 2)

Diel R, Sotgiu G, Andres S, et al. Cost of multidrug resistant tuberculosis in Germany—an update. Int J Infect Dis 2020 (published online Nov 2)

Dillard LK, Martinez R, Perez LL, et al. Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: a systematic review. J Infect 2021 (published online May 16)

Dodd PJ, Yuen C, Jayasooriya S, et al. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis 2021 (published online Feb 25)

Dooley KE, Rosenkranz SL, Conradie F, et al. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. Lancet Infect Dis 2021 (published online Feb 12)

Dorjee K, Topgyal S, Tsewang T, et al. Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: an impact assessment. PLoS Med 2021 (published online Jan 19)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»